MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Decision making in Huntington’s disease

    B. Heim, M. Peball, P. Ellmerer, C. Saft, S.M. von Hein, W. Poewe, K. Seppi, A. Djamshidian (Innsbruck, Austria)

    Objective: To investigate perceptual decision making and reflexion impulsivity in preclinical and manifest patients with Huntington’s disease (HD). Background: Huntington’s disease (HD) is an autosomal…
  • 2018 International Congress

    Driving performance of Huntington’s disease gene carriers

    M. Jacobs, E. Hart, Y. Mejia Miranda, G.J. Groeneveld, J. van Gerven, R. Roos (Leiden, Netherlands)

    Objective: To investigate if differences in driving performance between Huntington's disease (HD) gene carriers and healthy individuals can be detected with a driving simulator. Furthermore,…
  • 2018 International Congress

    Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy

    A. Lozza, A. Castagna, G. Castelnovo, E. Alfonsi, A. Montini, L. Marchetta, M. Fresia, A. Arrigo, R. Manni (Pavia, Italy)

    Objective: We report three cases of focal movement disorder following trauma or surgery. Oral therapies were ineffective in both patients and symptoms dramatically improved after…
  • 2018 International Congress

    Progressive encephalomyelitis with rigidity and myoclonus (PERM): Phenomenology, investigations and management of two recent cases

    T. Munteanu, Y. LLamas-Osorio, P. Cullinane, T. Lynch (Dublin, Ireland)

    Objective: To describe the diagnosis and treatment of two cases of anti-glycine receptor antibody positive PERM Background: PERM is a life-threatening autoimmune condition, which presents…
  • 2018 International Congress

    Diagnostic value and capability of DaT (dopamine-transporter) SEPCT scan to assess clinically uncertain Parkinsonism Diseases as a single institutional experience in Kuwait Population

    S. Al Tailji, M. Elgadafi1, W. Kamel, J. Al-Hashel (Kuwait, Kuwait)

    Objective: To evaluate the diagnostic value and capability of DaT scan to increase clinical confidence in order to confirm/rule out the diagnosis, change management and…
  • 2018 International Congress

    Eye movement disorders after cerebellar infaction

    M. Munteanu (Bucharest, Romania)

    Objective: This study aims to demostrate that the posterior cerebellar vermis controls both saccade precision and smooth pursuit velocity in humans. Background: The posterior vermis…
  • 2018 International Congress

    Spectrum of movement disorders with anti-neuronal antibodies: Case series

    A. Kumar, S. Mehta, V. Lal (Chandigarh, India)

    Objective: To study the spectrum of clinical features of antineuronal antibody associated neurological syndromes presenting at a tertiary care centre in North India. Background: Movement…
  • 2018 International Congress

    The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

    T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)

    Objective: We aimed to explore the frequency and clinical impact of APOε4 polymorphisms in a cohort of Ashkenazi Jewish (AJ) patients with Dementia with Lewy…
  • 2018 International Congress

    A Young Man with Multiple System Atrophy: A Case Report

    DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)

    Objective: To describe the case of a young man with the diagnosis of probable Multiple System Atrophy. Background: MSA is a complex neurodegenerative disorder. The…
  • 2018 International Congress

    Burden among Patients with Progressive Supranuclear Palsy

    T. Xie, X. Ye, L. Kandukuri, Y. Bao (Chicago, IL, USA)

    Objective: To quantify the economic costs and examine the most common co-morbidities of patients with progressive supranuclear palsy (PSP) in the United States. Background: PSP…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley